The degree of bowel remission predicts phenotype progression in Crohn's disease
United European Gastroenterology Journal · 2024
DOI: 10.1002/ueg2.12581 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Samuel Raimundo Fernandes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Gastrenterologia e Hepatologia, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisboa, Portugal. Hauptthemen laut MEDLINE: Crohn Disease, Disease Progression, Remission Induction, Phenotype. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Patients with Crohn's disease (CD) are at risk of progressing from inflammatory to stricturing and penetrating phenotypes. The influence of the depth of remission on the risk of progression has not been adequately evaluated.
Methods
A retrospective cohort study including surgically naïve CD patients with inflammatory phenotype evaluated concomitantly by magnetic resonance enterography and colonoscopy. The degree of remission was correlated with the risk of progressing to stricturing and penetrating phenotypes.
Results
Three hundred nineteen CD patients were included: 27.0% with transmural remission, 16.0% with isolated endoscopic remission, 14.4% with isolated radiologic remission, and 42.6% without remission. Patients with transmural remission presented the lowest rates of phenotype progression (1.2%), with a significant difference compared to isolated radiologic remission (10.9%, p = 0.019), to isolated endoscopic remission (19.6%, p ≤ 0.001), and to no remission (46.3%, p ≤ 0.001). In multivariate regression analysis, transmural remission (OR 0.017 95% CI 0.002–0.135, p < 0.001), isolated radiologic remission (OR 0.139 95% CI 0.049–0.396, p < 0.001), and isolated endoscopic remission (OR 0.301 95% CI 0.123–0.736, p = 0.008) resulted in lower rates of phenotype progression compared to no remission. No patient with transmural or isolated radiologic remission progressed to penetrating phenotypes.
Conclusion
The degree of bowel remission correlates with the risk of phenotype progression. Patients with transmural remission are at the lowest risk of progressing to stricturing and penetrating phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Serviço de Gastrenterologia e Hepatologia, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisboa, Portugal.
- Clínica Universitária de Gastrenterologia da Faculdade de Medicina de Lisboa, Lisboa, Portugal.
- Grupo de Estudos de Doença Inflamatória do Intestino (GEDII), Porto, Portugal.
- CINTESIS@RISE, Faculty of Medicine, University of Porto, Porto, Portugal.
ORCID-Profile: Samuel Raimundo Fernandes, Sofia Saraiva, Helena Cortez-Pinto
Zitieren
APA
Fernandes, S. R., Bernardo, S., Saraiva, S., Gonçalves, A. R., Moura Santos, P., Valente, A., Araújo Correia, L., Cortez-Pinto, H., & Magro, F. (2024). The degree of bowel remission predicts phenotype progression in Crohn's disease. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12581
Vancouver
Fernandes SR, Bernardo S, Saraiva S, Gonçalves AR, Moura Santos P, Valente A, et al. The degree of bowel remission predicts phenotype progression in Crohn's disease. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12581
BibTeX
@article{Fernandes2024,
author = {Fernandes, Samuel Raimundo and Bernardo, Sónia and Saraiva, Sofia and Gonçalves, Ana Rita and Moura Santos, Paula and Valente, Ana and Araújo Correia, Luís and Cortez-Pinto, Helena and Magro, Fernando},
title = {The degree of bowel remission predicts phenotype progression in Crohn's disease},
journal = {United European Gastroenterology Journal},
year = {2024},
doi = {10.1002/ueg2.12581}
}
EUVIMED